mRNA Vaccines and Therapeutics Market Share

Statistics for the 2023 & 2024 mRNA Vaccines and Therapeutics market share, created by Mordor Intelligence™ Industry Reports. mRNA Vaccines and Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of mRNA Vaccines and Therapeutics Industry

The market for mRNA vaccines and therapeutics is fragmented in nature due to the presence of several companies globally. Key players are implementing various strategies, including partnerships, mergers and acquisitions, geographic expansion, and strategic collaborations to expand their market presence. Some of the key companies dealing in the market studied are AstraZeneca, Pfizer Inc., Moderna, BioNTech, GlaxoSmithKline, Daiichi Sankyo, BioNTech SE, and among others.

mRNA Vaccine and Therapeutics Market Leaders

  1. Pfizer Inc.

  2. Moderna, Inc.

  3. BioNTech SE

  4. GlaxoSmithKline

  5. Daiichi Sankyo 

*Disclaimer: Major Players sorted in no particular order

mRNA Vaccines and Therapeutics Market Concentration

mRNA Vaccine and Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)